Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer

Published:2008-07 Issue:1-2 Volume:111 Page:13-17
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Chow Louis Wing-Cheong,Yip Adrian Yun-San,Loo Wings Tjing-Yung,Lam Chi-Kei,Toi Masakazu

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference32 articles.

1. Aromatization by skeletal muscle;Matsumine;J. Clin. Endocrinol. Metab.,1986

2. Estrogen and the risk of breast cancer;Clemons;New Engl. J. Med.,2001

3. Expression of aromatase protein and messenger ribonucleotide acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers;Lu;Endocrinology,1996

4. Aromatase inhibitors in breast cancer;Smith;New Engl. J. Med.,2003

5. The role of aromatase inhibitors in the treatment of metastatic breast cancer;Mouridsen;Semin. Oncol.,2003

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Current Oncology;2022-08-25

2. Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition;Breast Cancer Research;2021-02-15

3. Neoadjuvant Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors Combined with Endocrine Therapy in HR+/HER2− Breast Cancer: A Systematic Review and Meta-Analysis;Oncology Research and Treatment;2021

4. Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity;Biology;2020-12-01

5. Molecular docking analysis of COX-2 for potential inhibitors;BIOINFORMATION;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3